Log in
Biopta is a profitable, award-winning company spin-out from Glasgow Caledonian University (GCU). Established in 2002, to deliver commercial products and services developed by university employees, it employs 19 staff across its Glasgow and Beltsville (Maryland USA) offices. It specialises in the provision of instruments and services monitoring drug effects in ethically donated, healthy and diseased human tissue, and counts eight of the top 10 major pharmaceutical companies as clients. To date, Biopta has provided early stage testing on more than 400 new drugs, designed to treat conditions such as high blood pressure, asthma and irritable bowel syndrome, determining their efficacy and potential side effects.
The impact of the research by the Caledonian Environment Centre can be demonstrated by the shift in Scotland's recycling rates from 4% in 1998 when the Centre was established, to 40% in 2011. The Centre's research methods were embedded in assessment tools which led to Scottish Councils being provided with £64m of additional annual funding. The Remade Scotland programme, hosted and developed by the Centre, between 2000 and 2010, delivered change as the first recyclate UK market development programme, and was further developed across the UK: two years later leading to the establishment of Waste Resources Action Programme (WRAP).
Gender inequality affects workforce effectiveness. Our research has significantly increased awareness of factors which contribute to the paucity of female representation in the public sector. Notably it has shaped the policies and strategies of public sector agencies such the Scottish Government, Leadership Foundation in Higher Education, NHS and educational institutions such as universities and further education colleges. The research provided a platform for implementation of the Gender Equality Duty for the Scottish public sector.
The primary beneficiaries of Glasgow Caledonian University (GCU) research into the Gaelic cultural economy are Gaelic-speaking communities in Scotland. Additional beneficiaries are the Scottish broadcast media and their Gaelic-speaking viewing public. The research has:
The Unit's research into HIV testing has led to impacts on health policy (WHO and NICE guidelines) and services relating to HIV testing amongst vulnerable populations across Europe, and particularly, Scotland. The policies related to the frequency of HIV testing, increases in sites available for testing, and the scope of interventions to promote testing. These policies have contributed to significant increases in HIV testing, and a reduction in undiagnosed HIV infection, HIV related ill-health and AIDS deaths. For people living with HIV, this has enabled improved quality of life, better health and contributions to society.
Research by Dr S. Karly Kehoe at the Scottish Catholic Archives and the Highland Archive Centre (HAC) led to the discovery of source materials relating to connections between Scottish Highlanders and plantation slavery. Extensive archival work supported an exhibition at the HAC and a resource pack which currently supports teachers delivering the 'Atlantic Slave Trade' topic in the National 4/5 Curriculum for Excellence (History). The pack supports the 'Mandatory Content & Illustrative Areas' section and covers the 4 core areas for study: the Triangular Trade; Britain and the Caribbean; the Captive's Experience and Slave Resistance; the Abolitionist Campaigns.
Glasgow Caledonian University researchers have dramatically changed the manufacture of custom ankle-foot and foot orthoses through additive manufacturing (3D printing) combined with improved design personalisation. The research has beneficially impacted on health and well-being as new 3D printed orthoses have been designed and trialled with patients with positive outcomes reported. Moreover, European SME companies in the orthotic design and manufacture sector have benefitted through the commercialisation of new orthotic products and computer-based design optimisation software. The research has also led to raised global awareness of the capabilities of additive manufacturing for the orthotic sector and beneficially influenced manufacturing research and development funding at the European policy level.
GCU research into media coverage and public perceptions of poverty, and measures to tackle poverty has had an impact on policy making, policy content and the public discourse of poverty. Deprived communities have been the primary beneficiaries of this impact, e.g. GCU research helped secure pledges from all the main Scottish political parties to avoid stigmatising and socially divisive language in discussing poverty. Secondary beneficiaries have been campaigning organisations whose media engagement strategies have improved. Finally, GCU poverty research has informed the Scottish Government's Child Poverty Strategy and the child poverty measures of Community Planning Partnerships.
The researchers have delivered 10 funded studies (£700,000), 50+ peer-reviewed publications and five knowledge transfer conferences (750+ delegates). The samples presented led to materials being delivered to 100,000+ industry practitioners. Further, the international reach of UK OSH guidance is substantial, influencing Australia, Hong Kong, South Africa, and North America. The research helped improve Occupational Safety & Health (OSH) practices in major construction companies, with global reach, e.g. MACE (3,700 employees, over 69 countries, turnover £1bn), who implemented developed practices, resulting in 30% drop in accident rates. Our 'OSH communication images' are used in CITB training, delivered to over 100,000 workers.
Healthcare Associated Infections (HAI) can be an unintended consequence of healthcare delivery. They are caused by a range of organisms but are often preventable. GCU-led research has reduced avoidable infections in healthcare in the UK and Europe by stimulating policy debate and investment in new healthcare practice and influencing policy decisions, evidence guidelines, and educational practices. Important changes have been made to national and international approaches to meticillin-resistant Staphylococcus aureus (MRSA) screening with cost savings of £7.5 million to the NHS. 28 European countries now use the HAI point prevalence survey validation method determined by our research.